Pharmacokinetic and Bioequivalence Evaluation of Two Cefprozil Dispersible Tablets in Healthy Chinese Volunteers.

Xu, Lang; Su, Jianfen; Muhetaer, Halimulati; Zhang, Canhua; Huang, Chen; Tang, Yukuan; Fu, Xihua; Liang, Zhimin

Xu, Lang; Su, Jianfen; Muhetaer, Halimulati; Zhang, Canhua; Huang, Chen; Tang, Yukuan; Fu, Xihua; Liang, Zhimin.

Affiliation

Xu L; Guangzhou Panyu Central Hospital, Guangzhou, China.
Su J; School of Pharmacy, Guangdong Medical University, Dongguan, China.
Muhetaer H; The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.
Zhang C; Guangzhou Panyu Central Hospital, Guangzhou, China.
Huang C; Guangzhou Panyu Central Hospital, Guangzhou, China.
Tang Y; School of Pharmaceutical Science, Guangzhou Medical University, Guangzhou, China.
Fu X; Guangzhou Panyu Central Hospital, Guangzhou, China.
Liang Z; School of Pharmacy, Guangdong Medical University, Dongguan, China.

Clin Pharmacol Drug Dev ; 12(12): 1229-1233, 2023 12.

Article de En | MEDLINE | ID: mdl-37477442

Sujet(s)
Mots clés

bioequivalence; cefprozil; clinical trial; pharmacokinetics; safety

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Peuples d'Asie de l'Est Type d'étude: Clinical_trials Limites: Humans Langue: En Journal: Clin Pharmacol Drug Dev Année: 2023 Type de document: Article Pays d'affiliation: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google